Canadian Guidelines for Controlled Pediatric Donation After Circulatory Determination of Death-Summary Report
- PMID: 28925929
- PMCID: PMC5671796
- DOI: 10.1097/PCC.0000000000001320
Canadian Guidelines for Controlled Pediatric Donation After Circulatory Determination of Death-Summary Report
Erratum in
-
Canadian Guidelines for Controlled Pediatric Donation After Circulatory Determination of Death-Summary Report: Erratum.Pediatr Crit Care Med. 2018 Feb;19(2):178. doi: 10.1097/PCC.0000000000001415. Pediatr Crit Care Med. 2018. PMID: 29394233 Free PMC article. No abstract available.
Abstract
Objectives: Create trustworthy, rigorous, national clinical practice guidelines for the practice of pediatric donation after circulatory determination of death in Canada.
Methods: We followed a process of clinical practice guideline development based on World Health Organization and Canadian Medical Association methods. This included application of Grading of Recommendations Assessment, Development, and Evaluation methodology. Questions requiring recommendations were generated based on 1) 2006 Canadian donation after circulatory determination of death guidelines (not pediatric specific), 2) a multidisciplinary symposium of national and international pediatric donation after circulatory determination of death leaders, and 3) a scoping review of the pediatric donation after circulatory determination of death literature. Input from these sources drove drafting of actionable questions and Good Practice Statements, as defined by the Grading of Recommendations Assessment, Development, and Evaluation group. We performed additional literature reviews for all actionable questions. Evidence was assessed for quality using Grading of Recommendations Assessment, Development, and Evaluation and then formulated into evidence profiles that informed recommendations through the evidence-to-decision framework. Recommendations were revised through consensus among members of seven topic-specific working groups and finalized during meetings of working group leads and the planning committee. External review was provided by pediatric, critical care, and critical care nursing professional societies and patient partners.
Results: We generated 63 Good Practice Statements and seven Grading of Recommendations Assessment, Development, and Evaluation recommendations covering 1) ethics, consent, and withdrawal of life-sustaining therapy, 2) eligibility, 3) withdrawal of life-sustaining therapy practices, 4) ante and postmortem interventions, 5) death determination, 6) neonatal pediatric donation after circulatory determination of death, 7) cardiac and innovative pediatric donation after circulatory determination of death, and 8) implementation. For brevity, 48 Good Practice Statement and truncated justification are included in this summary report. The remaining recommendations, detailed methodology, full Grading of Recommendations Assessment, Development, and Evaluation tables, and expanded justifications are available in the full text report.
Conclusions: This process showed that rigorous, transparent clinical practice guideline development is possible in the domain of pediatric deceased donation. Application of these recommendations will increase access to pediatric donation after circulatory determination of death across Canada and may serve as a model for future clinical practice guideline development in deceased donation.
Conflict of interest statement
Dr. Weiss received funding from the Canadian Blood Services; he disclosed that he was recently nominated as medical director of Transplant Québec, a governmental nonprofit organ donation organization; and he disclosed government work. Dr. Hornby received funding from the Canadian Blood Services (paid research consultant and was paid for a portion of the work on this project). Dr. Sivarajan received funding from the Canadian Blood Services (hotel/travel for consensus meeting for guideline development) and from the Ontario Trillium Gift of Life Network (stipend paid for his role as hospital donation physician as part of provincial program). Dr. Appleby received funding from the Canadian Blood Services (employee where part of her paid time was spent supporting this work; sponsored travel and meeting costs associated with the face to face meetings). Dr. Farrell received funding from the Canadian Blood Services (payments made to defray travel expenses for attendance at two plenary meetings to plan the work and prepare the major portion of the article), Centre de soins de santé et de services sociaux des Laurentides (honorarium for lecture at a conference on head trauma organized by the health authority in May 2015), CHU Sainte-Justine Honorarium (lecture given during a Continuing Medical Education conference [Pédiatrie Plus] held outside the hospital, in November 2016), and the Canadian Paediatric Society (member of the Executive and Board of Directors of the Society, and a portion of her travel expenses are paid for attendance at Board meetings); and she disclosed that she is a designated organ donation physician specialist for her institution, and she works closely with Transplant-Québec. Dr. Goldberg received funding from the Canadian Blood Services (funding for travel to meetings for preparation of the article). Dr. Nakagawa received funding from UpToDate, and he disclosed that he is the Assistant Medical Director for Carolina Donor Services in Durham, NC. Dr. Barter received funding from Canadian Blood Services provided support for transportation to a meeting in October 2015 to commence the process of writing these guidelines. Dr. Dawson received funding from Canadian Blood Services (employer), and she disclosed work for hire. Dr. Dipchand’s institution received funding from the National Institutes of Health/National Institute of Allergy and Infectious Diseases. Dr. Hornby received funding the Canadian Blood Services. Dr. Langlois’ institution received funding from Astella Pharma Canada for a grant not related to the submitted work. Dr. Mack received funding for travel from the Canadian Blood Services. Dr. Mahoney received funding from the Canadian Blood Services. Dr. Shemie disclosed that he is a medical advisor for deceased organ donation at Canadian Blood Services, and he disclosed government work. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
Pediatric Donation After Circulatory Determination of Death: Canadian Guidelines Define Parameters of Consensus and Uncertainty.Pediatr Crit Care Med. 2017 Nov;18(11):1068-1070. doi: 10.1097/PCC.0000000000001322. Pediatr Crit Care Med. 2017. PMID: 29099447 No abstract available.
Similar articles
-
Ethics Guide Recommendations for Organ-Donation-Focused Physicians: Endorsed by the Canadian Medical Association.Transplantation. 2017 May;101(5S Suppl 1):S41-S47. doi: 10.1097/TP.0000000000001694. Transplantation. 2017. PMID: 28437370
-
Pediatric Donation After Circulatory Determination of Death: A Scoping Review.Pediatr Crit Care Med. 2016 Mar;17(3):e87-e108. doi: 10.1097/PCC.0000000000000602. Pediatr Crit Care Med. 2016. PMID: 26727103
-
National recommendations for donation after cardiocirculatory death in Canada: Donation after cardiocirculatory death in Canada.CMAJ. 2006 Oct 10;175(8):S1. doi: 10.1503/cmaj.060895. CMAJ. 2006. PMID: 17124739 Free PMC article.
-
An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of death.Am J Respir Crit Care Med. 2013 Jul 1;188(1):103-9. doi: 10.1164/rccm.201304-0714ST. Am J Respir Crit Care Med. 2013. PMID: 23815722
-
Controlled Donation After Circulatory Determination of Death.J Intensive Care Med. 2017 Mar;32(3):179-186. doi: 10.1177/0885066615625628. Epub 2016 Jul 7. J Intensive Care Med. 2017. PMID: 26905540 Review.
Cited by
-
Canadian Guidelines for Controlled Pediatric Donation After Circulatory Determination of Death-Summary Report: Erratum.Pediatr Crit Care Med. 2018 Feb;19(2):178. doi: 10.1097/PCC.0000000000001415. Pediatr Crit Care Med. 2018. PMID: 29394233 Free PMC article. No abstract available.
-
An Integrative Review on Exploring Organ Donation After Death by Circulatory Criteria in Canada.Prog Transplant. 2025 Sep;35(3):161-171. doi: 10.1177/15269248251349783. Epub 2025 Jun 13. Prog Transplant. 2025. PMID: 40509805 Free PMC article. Review.
-
Special issues in pediatric deceased organ donation.Intensive Care Med. 2019 Mar;45(3):361-363. doi: 10.1007/s00134-019-05523-2. Epub 2019 Feb 6. Intensive Care Med. 2019. PMID: 30725135 No abstract available.
-
Diagnostic test accuracy for cessation of circulation during death determination: a systematic review.Can J Anaesth. 2023 Apr;70(4):671-684. doi: 10.1007/s12630-023-02424-3. Epub 2023 May 3. Can J Anaesth. 2023. PMID: 37138156 Free PMC article.
-
Management of the Pediatric Organ Donor.J Pediatr Pharmacol Ther. 2019 Jul-Aug;24(4):276-289. doi: 10.5863/1551-6776-24.4.276. J Pediatr Pharmacol Ther. 2019. PMID: 31337990 Free PMC article. Review.
References
-
- Canadian Institute for Health Information: Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2004 to 2013. 2015. Available at: https://secure.cihi.ca/estore/productFamily.htm?locale=en&pf=PFC2864&lan.... Accessed April 1, 2017
-
- Martin DE, Nakagawa TA, Siebelink MJ, et al. Transplantation Society: Pediatric deceased donation-a report of the transplantation society meeting in Geneva. Transplantation 2015; 99:1403–1409. - PubMed
-
- Antommaria AH, Trotochaud K, Kinlaw K, et al. Policies on donation after cardiac death at children’s hospitals: A mixed-methods analysis of variation. JAMA 2009; 301:1902–1908. - PubMed
-
- Weiss MJ, Hornby L, Witteman W, et al. Pediatric donation after circulatory determination of death: A scoping review. Pediatr Crit Care Med 2016; 17:e87–e108. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical